Tudor-Eliade Ciuleanu

Function ESMO National Representative
Term 2017 – 2018
Address Prof. Dr. Ion Chiricuta Oncology Institute
34-36 Republicii Street



Prof. Dr. Tudor-Eliade Ciuleanu studied medicine at the Iuliu Haţieganu University of Medicine and Pharmacy in Cluj-Napoca, where he graduated in 1982. He completed his residency in Medical Oncology at the Prof. Dr. Ion Chiricuta Oncology Institute of Cluj-Napoca and at the Institute of Oncology Prof. Dr. Alexandru Trestioreanu, where he obtained the specialisation in Medical Oncology in 1988. 

In 1991 he moved to France and worked as Medical Oncology Specialist at the Gustave Roussy Institute of Oncology, Villejuif, while completing a post-graduate course on Chemotherapy at the University Paris-Sud. In 1993 he came back to Romania and got a PhD in Oncology at the University of Cluj-Napoca.

Prof. Ciuleanu is currently working as Senior Specialist in Medical Oncology at the Prof. Dr. Ion Chiricuta Institute and as Professor at the Iuliu Haţieganu University of Medicine and Pharmacy. His main fields of interest are clinical studies in molecular target therapies and chemotherapy in solid tumours; he has been involved as Principal Investigator in several clinical trials in solid tumours and lymphomas. 

Member of ESMO since 2000, Prof. Ciuleanu holds numerous national and international professional memberships, such as the American Society of Clinical Oncology (ASCO), the Central European Cooperative Group, the Balkan Union of Oncology (BUON), the Romanian National Society of Medical Oncology (SNOMR) and the Romanian Society of Radiotherapy and Medical Oncology (RSRMO) that he led as President in 2002-2003 and 2013-2014.

Prof. Ciuleanu has published more than 80 in extenso articles in ISI ranked publications and around 150 abstracts in international conferences and has authored and co-authored 3 books and 20 book chapters. He is also a member of the Editorial Board of several medical journals, including Journal of Clinical Oncology – Romanian Edition, Journal of Radiotherapy and Medical Oncology, Journal of BUON.